Diseases & Illness |

Osteonecrosis of the Jaw (ONJ) News

Merck Sued Over Fosamax

RSS News Feeds
Disease from Products
Osteonecrosis of the Jaw (ONJ)
Fosamax
 All RSS Feeds

At a glance:

New concerns arise over the class of osteoporosis medication known as biphosphonates. Merck, the maker of one of these drugs, Fosamax, is being sued for negligence in the promotion of this drug by not disclosing an alleged side effect, osteonecrosis of the jaw. 
 
This is a rare but painful condition in which the jawbone disintegrates, requiring reconstructive surgery. 
 
The lawsuit is a class action case, filed in Florida.

Merck under fire again as US lawsuit targets Fosamax

Pharma Times - 4/13/2006 6:38 AM

Merck & Co's legal team, already battling to defend thousands of lawsuits alleging injury caused by the company's Vioxx painkiller, will now have to fend off a class action lawsuit alleging Merck was negligent in promoting its osteoporosis drug Fosamax.
 
The new lawsuit, filed in Florida, alleges that Merck has tried to conceal Fosamax' side effects from patients and doctors, particularly a condition known as osteonecrosis of the jaw
 
· Read The Full Osteonecrosis of the Jaw (ONJ) Article From Pharma Times -->

· Read All Osteonecrosis of the Jaw (ONJ) News Stories -->

Comments On Osteonecrosis of the Jaw (ONJ) News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: